The Department of Cardiothoracic Surgery is a recognized leader in heart, lung and esophagus surgery. Our experience with complex cardiothoracic issues and knowledge of the latest advances have helped to establish NewYork-Presbyterian|Weill Cornell Medicine as a major referral center for cardiovascular and thoracic patients from around the world.

2023 CT Surgery group photo

Cardiac Surgery

The Division of Cardiac Surgery provides expert care to patients who need:

  • Coronary Artery Bypass Surgery
  • Valve repair/replacement
  • Aortic Aneurysm & Dissection Repaire
  • Minimally Invasive & Robotic Heart Surgery
  • Ventricular Assist Device & Heart Transplant
Learn More
Cardiac Surgery team

Thoracic Surgery

The Division of Thoracic Surgery offers the most advanced surgical care for:

  • Lung & Esophageal cancers
  • Thymoma
  • Achalasia
  • Hyperhidrosis
  • Hiatal Hernia
  • Lung Volume Reduction for Emphysema
  • Tracheobronchomalacia (TBM)
Learn More
Thoracic Surgery team

Why Choose Weill Cornell?

NewYork-Presbyterian & Weill Cornell Medicine - Cardiothoracic Surgery

New Advances

WCM Receives Milestone in Mitral Valve Repair for the 2nd Year

2024 Mitral Valve Award Seals
Weill Cornell's Department of Cardiothoracic Surgery has again been honored with the esteemed Mitral Valve Repair Reference Center Award from the American Heart Association and the Mitral Foundation for our second consecutive year. 
This recognition underscores our sustained leadership in mitral valve repair and our unwavering commitment to delivering exemplary cardiac care

Advocating for Surgical Aortic Valve Replacement: An Interview With Leonard N. Girardi, MD

Fascinating in-depth interview with Dr. Joel Dunning, Cardiothoracic Surgeon at James Cook University Hospital.

Dr. Leonard Girardi highlighting the efficacy and durability of Surgical Aortic Valve Replacement (SAVR). This was recently presented at 60th STS Annual meeting in San Antonio Texas "Drop the Wire, Pick Up the Knife: Bring SAVR Back!"

Dr. Girardi underscored the importance of putting patients first by ensuring clear communication on treatment options and post-surgical care.

Dr. Girardi with Dr. Joel Dunning

Less Invasive Early Lung Cancer Study Receives Top 10 Clinical Research Achievement Award

Nasser Altorki, MD

Dr. Nasser Altorki in OR

A Weill Cornell Medicine-led research team has been awarded a 2024 Top 10 Clinical Research Achievement Award from the Clinical Research Forum in recognition of an influential 2023 New England Journal of Medicine study on early-stage lung cancer resection.

The clinical trial results were published Feb. 9, 2023 by a team led by Dr. Nasser Altorki, chief of the Division of Thoracic Surgery in the Department of Cardiothoracic Surgery at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, and co-investigators from Duke University as well as investigators from 83 hospitals across the United States, Canada and Australia. The trial found that a surgery that removes only a portion of one of the five lobes that comprise a lung is as effective as removing an entire lobe for certain early-stage lung cancer patients.

Click here to learn more about the article

Up and-coming Bronchoscopic Ablation Therapies for Treatment of Lung Cancer

Click here to lean more about Dr. Ali and Dr. Musani's article

Clinical Trials

The Cardiothoracic Surgery Department conducts a robust clinical trials program to evaluate the effectiveness of new treatments and medications that have the potential to improve the management of patients with heart, lung, and esophageal disease. The outcomes of heart, lung, and esophageal operations can be improved with technical innovations.

Current Clinical Trials



Ranked #6 in Adult Cardiology & Heart Surgery Hospital in the nation and #1 in NYC by U.S. News and World Report

Ranked #1 in Best Regional Hospitals in U.S. News



America’s 50 Best Hospitals for Cardiac Surgery Award™ by Healthgrade

America’s 100 Best Hospitals for Cardiac Care Award™ by Healthgrade

Check out our X feed for the latest news.